多维度疼痛管理结合正念减压疗法对肺癌放化疗患者睡眠的影响

Impact of Multidimensional Pain Management Combined with Mindfulness-based Stress Reduction on Sleep in Lung Cancer Patients Undergoing Chemoradiotherapy

目的:分析多维度疼痛管理结合正念减压疗法对肺癌放化疗患者睡眠的影响。方法:选取2022年2月至2024年2月福建省肿瘤医院行放化疗治疗的肺癌患者94例作为研究对象,随机分为对照组和观察组,每组47例。对照组采用常规护理,观察组采用多维度疼痛管理+正念减压疗法干预。比较2组的心境状态、疼痛程度、自我感受负担及睡眠质量。结果:观察组的简式简明心境问卷(BPOMS-SF)评分、视觉模拟评分法(VAS)评分及自我感受负担评价量表(SPBS-CP)评分均低于对照组(P<0.05)。观察组睡眠时间、入睡时间、日间功能障碍、睡眠效率、睡眠质量、睡眠药物及睡眠障碍评分均低于对照组(均P<0.05)。观察组睡眠深度、夜间觉醒、睡眠潜伏期、重回入睡及睡眠质量评分均高于对照组(均P<0.05)。结论:多维度疼痛管理+正念减压疗法有利于改善肺癌放化疗患者的心境状态,减轻疼痛程度与自我感受负担,提升睡眠质量。

Objective:To analyze the impact of multidimensional pain management combined with mindfulness-based stress reduction(MBSR)on the sleep of lung cancer patients undergoing chemoradiotherapy.Methods:A total of 94 lung cancer patients receiving chemoradiotherapy at Fujian Provincial Cancer Hospital from February 2022 to February 2024 was selected and randomly divided into a control group and an observation group,with 47 patients in each group.The control group received routine care,while the observation group received multidimensional pain management combined with MBSR.The two groups were compared in terms of mood state,pain levels,perceived burden,and sleep quality.Results:The Brief Profile of Mood State Short Form(BPOMS-SF),Visual Analog Scale(VAS),and Self-Perceived Burden Scale for Cancer Patients(SPBS-CP)scores in the observation group were lower than those in the control group(P<0.05).The observation group had lower scores for sleep duration,sleep latency,daytime dysfunction,sleep efficiency,sleep quality,use of sleep medications,and sleep disturbance compared to the control group(all P<0.05).Additionally,the observation group scored higher than the control group in terms of sleep depth,night awakening,sleep latency,returning to sleep,and overall sleep quality(all P<0.05).Conclusion:Multidimensional pain management combined with MBSR can improve mood states,reduce pain levels and perceived burden,and enhance sleep quality in lung cancer patients undergoing chemoradiotherapy.